Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2014 · 10-Q
Revenue$0.00$0.00— vs Q2 2013 Net Income-$667.55K-$667.55KN/M vs Q2 2013 EPS Diluted-$0.01-$0.01N/M vs Q2 2013 Operating Income-$800,710N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end